TIEN VO: Open Payments
NPI 1891964904 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 36 payments from 19 companies in 2025. Trend: 2023 $770 · 2024 $511 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $194 |
| Abbott Laboratories | 2 | $163 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| ABBVIE INC. | 3 | $68 |
| GlaxoSmithKline, LLC. | 2 | $65 |
| Radius Health, Inc. | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Madrigal Pharmaceuticals | 1 | $37 |
| PFIZER INC. | 2 | $31 |
Products named: FREESTYLE LIBRE 3, Wegovy, TEZSPIRE, VRAYLAR, AREXVY, AIRSUPRA, Kerendia, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
